Evaluation of Diquafosol after femtosecond laser-assisted cataract surgery

Evaluation of Diquafosol after femtosecond laser-assisted cataract surgery - Evaluation of Diquafosol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039491

Enrollment

Registered

2020-02-15

Start date

2020-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye

Interventions

diquafosol treatment (6 times a day) or non treatment diquafosol treatment for 30 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients after femtosecond-laser-assisted cataract surgery for both eyes

Exclusion criteria

Exclusion criteria: severe glaucoma, severe diabetic retinopathy,

Design outcomes

Primary

Measure	Time frame
fidings of cornea, visual acuiaty	—

Countries

Japan

Contacts

Public ContactKenichiro Yamazaki

Omiya Nanasato Eye Institute Ophthalmology

karamawari@msn.com81-48-686-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026